Dow Up 0.05% Nasdaq Up 0.17%

VIVUS, Inc. (VVUS)

-NasdaqGS
1.14 Down 0.03(2.56%) Feb 24, 4:00PM EST
Prev Close:1.17
Open:1.16
Bid:1.04 x 500
Ask:1.14 x 3500
1y Target Est:2.80
Beta:0.335849
Earnings Date:Mar 7 - Mar 13 (Est.)
Day's Range:1.12 - 1.16
52wk Range:0.93 - 1.85
Volume:465,766
Avg Vol (3m):465,774
Market Cap:119.52M
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSDown 2.56%119.52M
LLYUp 0.39%86.94B
PFEUp 0.59%207.90B
GSKUp 0.17%98.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.09
Quarterly EPS Est (Dec-16) :0.23
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-16.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback